What began as a spark during a HESI ITC business meeting evolved into a dedicated Immunotoxicology session at the BioSafe Spring 2024 meetingāand today, weāre proud to share the result: a timely new publication in mAbs, authored by experts in HESIās Immuno-Safety Technical Committee.
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies
mAbs, 2025